WILMINGTON, DE: Chemicals giant DuPont has appointed Pfizer VP AnnaMaria DeSalva to the newly created role of VP of corporate communications, overseeing the company's strategic communications and brand management.
She will start in the role on March 10, reporting to DuPont SVP James Collins.
The role was created to give DuPont, which ranked number 72 on the most recent edition of the Fortune 500 list, a fully integrated, dedicated communications organization, said Collins.
“[DeSalva] will come in and take a fresh look at the strategic elements of our communications strategy and messaging and how we are talking about ourselves to our investors, customers, and also how we talk about where we are headed internally,” he explained. “She will look at how communications can enable our business strategies and corporate brand going forward.”
DeSalva will join DuPont from Pfizer, where she is VP of corporate affairs in the company's biopharma innovation and outcomes business. She will wrap up that role until she starts in the new position at DuPont next month. DeSalva said she will not be replaced in the Pfizer role, and the company will instead restructure her group and direct reports.
Previously, DeSalva was adviser for risk communications for the US Food and Drug Administration, worldwide director of healthcare for Hill & Knowlton, worldwide MD of healthcare for GCI Group, and director of the Bristol-Myers Squibb Foundation.
“I have split my career between the services side and consulting, and went deep for a pharma company like Pfizer,” DeSalva said. “I feel like I can bring those experiences together and help DuPont take the next several steps.”
As DeSalva enters the role, DuPont chief marketing and sales officer Scott Coleman will step down. Coleman had overseen the company's corporate marketing and sales organization, which will be moved under Collins.
DeSalva will manage global director of corporate communications Colleen Rooney, head of global public affairs and director of corporate communications Anthony Farina, and creative and global director of corporate communications Erich Parker. She will also serve as a member of DuPont's corporate operating team.
“[Coleman] has elected to leave the company to pursue another opportunity,” said Collins. “This is not connected to [DeSalva's] hire.”
Last October, DuPont announced the spinoff of its performance chemicals business. The company said last month that Mark Vergano will become CEO of the new corporation. Ellen Kullman will remain CEO of DuPont.
In the fourth quarter of last year, the company reported $7.7 billion in revenue, which was a 5% increase over the same quarter of the previous year. Its Q4 profit more than doubled compared with Q4 2012.